Clinical Trials
31 trialsETCABIO
University Hospital, Angers
MSTH-CAR001
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
EHCancer
Zagazig University
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
The Affiliated People's Hospital of Ningbo University
UCAR-T_MM-XA
Xi'an No.3 Hospital
ALHERT
University Hospital, Angers
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Anhui Provincial Hospital
IPoD-790
Tel-Aviv Sourasky Medical Center
Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells
Tel-Aviv Sourasky Medical Center
ECAR01
Anhui Provincial Hospital
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
The Third Affiliated Hospital of Southern Medical University
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
The Affiliated People's Hospital of Ningbo University
Integrative Therapies in Multiple Myeloma
Bnai Zion Medical Center
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation
Hospital Galdakao-Usansolo
RAT-HEMATO
University Hospital, Angers
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
Sheba Medical Center
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
KyDaR
Tel-Aviv Sourasky Medical Center
Velcadito
Basque Health Service
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
Shandong Provincial Hospital
MM-POM-2018
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma
Henan Cancer Hospital
Study of BCMA CAR-T in Multiple Myeloma
Henan Cancer Hospital
Lonquek for Autologous Stem Cell Mobilization
Sheba Medical Center
Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Sheba Medical Center
Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma
Bayside Health
Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients
Wolfson Medical Center
The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma
Centre National de Greffe de Moelle Osseuse
Atorvastatin in Myeloma
Bayside Health